Literature DB >> 27326335

Development of Potent and Selective S. aureus Sortase A Inhibitors Based on Peptide Macrocycles.

Inmaculada Rentero Rebollo1, Shawna McCallin2, Davide Bertoldo1, José Manuel Entenza2, Philippe Moreillon2, Christian Heinis1.   

Abstract

Sortases are transpeptidase enzymes that anchor surface proteins, including virulence factors, to the cell wall of Gram-positive bacteria, and they are potential targets for the development of anti-infective agents. While several large compound libraries were searched by high-throughput screening, no high-affinity inhibitors of sortases could be developed to date. Here, we applied phage display to screen billions of peptide macrocycles against sortase A (SrtA) of Staphylococcus aureus (S. aureus). We were able to identify potent and selective inhibitors of SrtA that blocked SrtA-mediated anchoring of synthetic substrates to the surface of live S. aureus cells. A region present in all inhibitory peptides (Leu-Pro-Pro) resembled the natural substrates of SrtA (Leu-Pro-Xaa-Thr-Gly), suggesting that the macrocycles bind to the enzyme's active site and that they form similar molecular contacts as natural substrates. The evolved peptide macrocycles may be used as lead structures for the development of potent peptidomimetic SrtA inhibitors.

Entities:  

Keywords:  Bicyclic peptide; Staphylococcus aureus; peptide macrocycle; phage display; sortase

Year:  2016        PMID: 27326335      PMCID: PMC4904248          DOI: 10.1021/acsmedchemlett.6b00045

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  30 in total

1.  A biosynthetic strategy for re-engineering the Staphylococcus aureus cell wall with non-native small molecules.

Authors:  James W Nelson; Alexander G Chamessian; Patrick J McEnaney; Ryan P Murelli; Barbara I Kazmierczak; Barbara I Kazmiercak; David A Spiegel
Journal:  ACS Chem Biol       Date:  2010-10-05       Impact factor: 5.100

Review 2.  Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus.

Authors:  Timothy J Foster; Joan A Geoghegan; Vannakambadi K Ganesh; Magnus Höök
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

Review 3.  Phage selection of bicyclic peptides.

Authors:  Inmaculada Rentero Rebollo; Christian Heinis
Journal:  Methods       Date:  2013-01-10       Impact factor: 3.608

4.  Discovery and structure-activity relationship studies of irreversible benzisothiazolinone-based inhibitors against Staphylococcus aureus sortase A transpeptidase.

Authors:  Dmitrijs Zhulenkovs; Zhanna Rudevica; Kristaps Jaudzems; Maris Turks; Ainars Leonchiks
Journal:  Bioorg Med Chem       Date:  2014-09-16       Impact factor: 3.641

5.  Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections.

Authors:  S K Mazmanian; G Liu; E R Jensen; E Lenoy; O Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

6.  Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif.

Authors:  H Ton-That; G Liu; S K Mazmanian; K F Faull; O Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  The structure of the Staphylococcus aureus sortase-substrate complex reveals how the universally conserved LPXTG sorting signal is recognized.

Authors:  Nuttee Suree; Chu Kong Liew; Valerie A Villareal; William Thieu; Evgeny A Fadeev; Jeremy J Clemens; Michael E Jung; Robert T Clubb
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

8.  The role of Staphylococcus aureus sortase A and sortase B in murine arthritis.

Authors:  Ing-Marie Jonsson; Sarkis K Mazmanian; Olaf Schneewind; Tomas Bremell; Andrzej Tarkowski
Journal:  Microbes Infect       Date:  2003-07       Impact factor: 2.700

Review 9.  Waves of resistance: Staphylococcus aureus in the antibiotic era.

Authors:  Henry F Chambers; Frank R Deleo
Journal:  Nat Rev Microbiol       Date:  2009-09       Impact factor: 60.633

10.  Bicyclic peptides with optimized ring size inhibit human plasma kallikrein and its orthologues while sparing paralogous proteases.

Authors:  Vanessa Baeriswyl; Helen Rapley; Lisa Pollaro; Catherine Stace; Dan Teufel; Edward Walker; Shiyu Chen; Greg Winter; John Tite; Christian Heinis
Journal:  ChemMedChem       Date:  2012-04-11       Impact factor: 3.466

View more
  5 in total

1.  Lysine-Targeted Reversible Covalent Ligand Discovery for Proteins via Phage Display.

Authors:  Mengmeng Zheng; Fa-Jie Chen; Kaicheng Li; Rahi M Reja; Fredrik Haeffner; Jianmin Gao
Journal:  J Am Chem Soc       Date:  2022-08-17       Impact factor: 16.383

2.  A Cell-based Screen in Actinomyces oris to Identify Sortase Inhibitors.

Authors:  Jason E Gosschalk; Chungyu Chang; Christopher K Sue; Sara D Siegel; Chenggang Wu; Michele D Kattke; Sung Wook Yi; Robert Damoiseaux; Michael E Jung; Hung Ton-That; Robert T Clubb
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

3.  N-Terminal cysteine mediated backbone-side chain cyclization for chemically enhanced phage display.

Authors:  Mengmeng Zheng; Fredrik Haeffner; Jianmin Gao
Journal:  Chem Sci       Date:  2022-06-30       Impact factor: 9.969

4.  Asymmetric Disulfanylbenzamides as Irreversible and Selective Inhibitors of Staphylococcus aureus Sortase A.

Authors:  Fabian Barthels; Gabriella Marincola; Tessa Marciniak; Matthias Konhäuser; Stefan Hammerschmidt; Jan Bierlmeier; Ute Distler; Peter R Wich; Stefan Tenzer; Dirk Schwarzer; Wilma Ziebuhr; Tanja Schirmeister
Journal:  ChemMedChem       Date:  2020-03-25       Impact factor: 3.466

5.  New Tripeptide Derivatives Asperripeptides A-C from Vietnamese Mangrove-Derived Fungus Aspergillus terreus LM.5.2.

Authors:  Elena V Girich; Anton B Rasin; Roman S Popov; Ekaterina A Yurchenko; Ekaterina A Chingizova; Phan Thi Hoai Trinh; Ngo Thi Duy Ngoc; Mikhail V Pivkin; Olesya I Zhuravleva; Anton N Yurchenko
Journal:  Mar Drugs       Date:  2022-01-17       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.